Evidence map›Paper›PMID 30981698›Full record

ReviewTranslational research : the journal of laboratory and clinical medicine2019

Cellular senescence and radiation-induced pulmonary fibrosis.

Yonghan He, Dinesh Thummuri, Guangrong Zheng, Paul Okunieff, Deborah E Citrin, Zeljko Vujaskovic, Daohong Zhou

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Translational research : the journal of laboratory and clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05637216 (A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients), which is not on this map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05637216 phase2active not recruitingnot on this mapstarted 2023, after this paper: background citation

A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

TypeinterventionalSponsorShaw Cancer CenterRan2023 to 2027Enrolled43ConditionsRadiation Induced FibrosisArmsLosartan 25 milligram capsule, Placebo
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Oroxylin A FromCanadian respiratory journal · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. A Functional VariantAmerican journal of respiratory cell and molecular biology · 2025
    Article
  19. Senotherapy for chronic lung disease.Pharmacological reviews · 2025
    Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yonghan HeDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida.
Dinesh ThummuriDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida.
Guangrong ZhengDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida.
Paul OkunieffDepartment of Radiation Oncology, College of Medicine, University of Florida, Gainesville, Florida.
Deborah E CitrinCenter for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Zeljko VujaskovicDepartment of Radiation Oncology, College of Medicine, University of Maryland, Baltimore, Maryland.
Daohong ZhouDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida; Department of Radiation Oncology, College of Medicine, University of Florida, Gainesville, Florida. Electronic address: zhoudaohong@cop.ufl.edu.
University of Florida · USCenter for Cancer Research · USUniversity of Maryland, Baltimore · US

Funding

Mechanisms of Normal Tissue Toxicity From IrradiationZIABC010850 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CITRIN, DEBORAH · 2009 to 2025
$19.4M
Role of Senescent Cells in Radiation-induced Pulmonary FibrosisR01CA219836 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2017 to 2021
$1.8M
Ionizing radiation induced hematological malignanciesR01CA211963 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI ZHOU, DAOHONG · 2017 to 2021
$1.8M
NCI NIH HHS R01 CA211963NCI NIH HHS R01 CA219836
6 · The paper itself

Abstract

Radiation-induced pulmonary fibrosis (RIPF) is a serious treatment complication that affects about 9%-30% cancer patients receiving radiotherapy for thoracic tumors. RIPF is characterized by progressive and irreversible destruction of lung tissues and deterioration of lung function, which can compromise quality of life and eventually lead to respiratory failure and death. Unfortunately, the mechanisms by which radiation causes RIPF have not been well established nor has an effective treatment for RIPF been developed. Recently, an increasing body of evidence suggests that induction of senescence by radiation may play an important role in RIPF and clearance of senescent cells (SnCs) with a senolytic agent, small molecule that can selectively kill SnCs, has the potential to be developed as a novel therapeutic strategy for RIPF. This review discusses some of these new findings to promote further study on the role of cellular senescence in RIPF and the development of senolytic therapeutics for RIPF.

Indexed as

Cellular SenescenceAnimalsHumansIdiopathic Pulmonary FibrosisModels, BiologicalRadiation Injuries

Identifiers

PMID30981698
PMCPMC6857805
OpenAlexW2924819531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.